Industry

India EMC Immunity Testing Markets, 2021-2022 & 2028: Advancements in 5G Infrastructure & Opportunities in Growing Adoption of Electric Vehicles – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India EMC immunity testing market Forecast to 2028 – COVID-19 Impact and Analysis – by Offering, Industry Vertical and Testing Offering” report has been added to ResearchAndMarkets.com’s offering. India EMC Immunity Testing Market size was valued at US$ 54.01 million in 2021 and is projected to reach US$ 102.37 million by 2028; it … [Read more…]

Global Reprocessed Medical Devices Markets Report 2021-2028: Strategic Initiatives by Players & Increasing FDA Approvals of Reprocessed Medical Devices – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Reprocessed Medical Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product And End User” report has been added to ResearchAndMarkets.com’s offering. The reprocessed medical devices market is projected to reach US$ 5,653.87 million by 2028 from US$ 2,087.36 million in 2021; it is expected to grow at a CAGR … [Read more…]

Modra Pharmaceuticals Presents In-Depth Data Analysis from Lower Dose Cohort in Phase 2b Study of Oral Taxane ModraDoc006/r in mCRPC Patients at 2022 ASCO Annual Meeting

ModraDoc006/r at 20-20/200-100mg dosage eliminated neutropenia and significantly decreased neuropathy while maintaining efficacy levels comparable to intravenous (IV) docetaxel Based on strong safety data and encouraging efficacy from the randomized Phase 2b trial, the 20-20/200-100mg dose has been selected for use in planned Phase 3 clinical trial AMSTERDAM–(BUSINESS WIRE)–Modra Pharmaceuticals (“Modra”) today announced the final … [Read more…]

Insights on the Healthcare Interoperability Solutions Global Market to 2027 – Featuring Cerner, Infor and Koninklijke Philips Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare Interoperability Solutions Market Research Report by Component (Services and Software), Level, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Interoperability Solutions Market size was estimated at USD 2,934.37 million in … [Read more…]

WAATR PureMax 4D & CrazyCap Named Winners of 2022 German Innovation Awards

Water Bottle Caps with Integrated Deep UV LEDs Recognized for Excellence in Business to Consumer: Travel, Sports & Outdoor Goods BERLIN–(BUSINESS WIRE)–#sustainablehydration–During an awards ceremony on May 24, 2022, the German Innovation Awards named both WAATR PureMax 4D and CrazyCap as winners in Business to Consumer: Travel, Sports & Outdoor Goods. The German Innovation Award … [Read more…]

iOnctura to Present at ASCO IOA-244 Showing Highly Promising Impact on Overall Survival for Patients With Metastatic and Refractory Uveal Melanoma

13 of 16 metastatic Uveal Melanoma (UM) patients continue in trial with promising overall survival rate at 1 year Excellent safety allowed for chronic administration with no dose alterations, achieving intended pharmacological effect Tregs reduced by IOA-244 in peripheral blood and tumor tissue, supporting mechanism of action GENEVA, Switzerland–(BUSINESS WIRE)–iOnctura SA, a clinical-stage oncology company … [Read more…]

Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that an abstract reporting preliminary data from the two Phase I trials assessing TG4050, its individualized neoantigen cancer vaccine, has been selected for a poster presentation at the American Society of Clinical … [Read more…]

Taro Provides Results for the Year Ended March 31, 2022

HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022. Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021   The quarter ended March 31, 2022, includes one month’s results from the February 28th acquisition of Alchemee. … [Read more…]

Alpine Immune Sciences Announces Presentations at the 2022 EULAR and ASCO Annual Meetings

– ALPN-303 Novel Preclinical Data and Preliminary Phase 1 Data at EULAR – – Davoceticept (ALPN-202) Monotherapy Update and Trials in Progress Poster for Pembrolizumab Combination Study at ASCO – SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today … [Read more…]

4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

– Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months – Study sites are open for patient enrolment LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today … [Read more…]